Convergence Seminar
Thursday, April 16, 2026

Jussi Taipale, PhD

Group Leader, Wellcome Sanger Institute, Hinxton, UK
Professor of Medical Systems Biology, Karolinska Institutet, Stockholm, Sweden
Professor of Medical Systems Biology, University of Helsinki

Professor Jussi Taipale obtained his Ph.D. at the University of Helsinki in 1996 and continued at the University of Helsinki for his post doctorate before moving to Johns Hopkins University (Baltimore, MD, USA). Since 2003, he has headed an independent research laboratory focusing on molecular basis of regulation of gene expression, and systems biology of growth control and cancer. He has published 115 articles of which sixteen are in the most prestigious scientific journals (Nature, Science and Cell), won numerous awards and grants (e.g., Anders Jahre Prize for Young Researchers, EMBO Young Investigator, ERC Advanced Grant and Vetenskapsrådet Distinguished Professor Program (Rådsprofessor)) and is internationally recognized as a leader in the field of genomics and systems biology. In 2012 Professor Taipale was elected as Member of the Nobel Assembly at the Karolinska Institutet, which awards the Nobel Prize in Physiology or Medicine. In 2025 he took up the position of Group Leader at the Wellcome Sanger Institute, UK and also maintains research groups at University of Helsinki, Finland and Karolinska Institutet, Sweden. 

The Taipale group’s main expertise is high-throughput screening using cDNA (Varjosalo et al. Cell 2008) and RNA interference (Björklund et al. Nature 2006), and computational, experimental and structural methods to identify transcription factor binding specificities and causative regulatory mutations in non-protein coding DNA (see Xie et al. Nature 2025; Morgunova et al. NSMB 2025; Yin et al., Science 2017; Jolma et al., Cell 2013 and Nature 2015; Yan et al., Cell 2013 and Nature 2021). In addition, the Taipale group has extensive expertise on mouse models of gene and regulatory region function (see Dumont et al., Science 1998; Ma et al., Cell 2002; Hallikas et al. Cell 2006; Dave et al., eLife 2018; Sur et al., Science 2012, LSA 2025).

Details

Dates
April 16, 2026
Time
11:00am-12:00pm PDT
Location
Mahley Auditorium
Contact(s)
CSV file successfully filtered and rewritten.CSV file successfully filtered and rewritten.





The Convergence Seminar is organized by Gladstone’s Institute for Data Science and Biotechnology. This seminar series brings together scientists from varying disciplines to solve complex scientific questions and accelerate the path to cures.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.